Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,079 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05605535 | Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer | active not recruiting | Phase 2 | 88 | CanariaBio Inc.INDUSTRY | 1 | Apr 1, 2026 | clinicaltrials |
| NCT05862012 | Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1) | recruiting | Phase 1 | 200 | Ichnos Sciences SAINDUSTRY | 7 | Apr 1, 2026 | clinicaltrials |
| NCT02138734 |
| A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer |
| active not recruiting |
| Phase 1 / Phase 2 |
| 369 |
| ImmunityBio, Inc.INDUSTRY |
| 3 |
| Mar 31, 2026 |
| clinicaltrials |
| NCT07241091 | SurgiPerito Trial: High-Purity Type-I Collagen for Peritoneal Reconstruction After Cytoreductive Surgery | completed | N/A | 60 | Adichunchanagiri Institute of Medical Sciences, B G NagaraOTHER | 1 | Mar 30, 2026 | clinicaltrials |
| NCT07360730 | High-Purity Type I Collagen Nerve Wrapping in Peripheral Nerve Procedures: A Prospective Registry | completed | N/A | 40 | Adichunchanagiri Institute of Medical Sciences, B G NagaraOTHER | 1 | Mar 30, 2026 | clinicaltrials |
| NCT07219316 | Regenerative Collagen Scaffold for Breast Volume Restoration After Breast Cancer Excision | completed | N/A | 40 | Adichunchanagiri Institute of Medical Sciences, B G NagaraOTHER | 1 | Mar 27, 2026 | clinicaltrials |
| NCT07480005 | To Revisit the Yield of Staging Laparoscopy in Hepatopancreatobiliary Malignancies | recruiting | — | 350 | Institute of Liver and Biliary Sciences, IndiaOTHER | 1 | Mar 23, 2026 | clinicaltrials |
| NCT04211337 | A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer(LIBRETTO-531) | active not recruiting | Phase 3 | 291 | Loxo Oncology, Inc.INDUSTRY | 20 | Mar 19, 2026 | clinicaltrials |
| NCT06876038 | Low-cost Screening and Image-guided Photodynamic Therapy (PDT) of Premalignant and Malignant Oral Lesions | not yet recruiting | Phase 2 | 65 | University of Massachusetts, BostonOTHER | 1 | Mar 19, 2026 | clinicaltrials |
| NCT05654623 | A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast Cancer(VERITAC-2) | active not recruiting | Phase 3 | 624 | PfizerINDUSTRY | 31 | Mar 18, 2026 | clinicaltrials |
| NCT06726265 | Study of Eftilagimod Alfa (Efti) in Combination With Pembrolizumab and Chemotherapy Versus Placebo in Combination With Pembrolizumab and Chemotherapy in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) (TACTI-004) | active not recruiting | Phase 3 | 756 | Immutep S.A.S.INDUSTRY | 27 | Mar 18, 2026 | clinicaltrials |
| NCT07478900 | Tumor Margin Skin Tattooing Before Neo-adjuvant Chemotherapy in Patients With Breast Cancer(TUMS) | recruiting | N/A | 30 | All India Institute of Medical Sciences, BhubaneswarOTHER | 1 | Mar 18, 2026 | clinicaltrials |
| NCT07436988 | Affordable Made-in-India Microspheres for Liver Cancer Therapy(ReLIVE) | not yet recruiting | Phase 1 | 18 | Post Graduate Institute of Medical Education and Research, ChandigarhOTHER | 1 | Mar 12, 2026 | clinicaltrials |
| NCT07215026 | Understanding Non-small Cell Lung Cancer Patient Characteristics, Treatment Patterns and Outcomes(UNCOVER) | completed | — | 833 | AstraZenecaINDUSTRY | 1 | Mar 10, 2026 | clinicaltrials |
| NCT03141021 | Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors | recruiting | — | 1,050 | Washington University School of MedicineOTHER | 5 | Mar 9, 2026 | clinicaltrials |
| NCT03573960 | A Study to Evaluate the Safety and Efficacy of Lenvatinib in Participants With Refractory Differentiated Thyroid Cancer | completed | Phase 4 | 50 | Eisai Pharmaceuticals India Pvt. LtdINDUSTRY | 1 | Mar 6, 2026 | clinicaltrials |
| NCT07453472 | Comparison of Topical Photodynamic Therapy With Topical Calcipotriol in Management of Oral Leukoplakia(PDT CALCI HOL) | not yet recruiting | Phase 3 | 166 | Dr. Shalini GuptaOTHER | 1 | Mar 6, 2026 | clinicaltrials |
| NCT07455097 | COMBINED PSMA-PET/CT AND MRI STAGING IN INTERMEDIATE AND HIGH-RISK PATIENTS PROSTATA-CANCER (COMBINE-P)(COMBINE-P) | active not recruiting | — | 600 | Heinrich-Heine University, DuesseldorfOTHER | 7 | Mar 6, 2026 | clinicaltrials |
| NCT04494425 | Study of Trastuzumab Deruxtecan (T-DXd) vs Investigator's Choice Chemotherapy in HER2-low, Hormone Receptor Positive, Metastatic Breast Cancer(DB-06) | active not recruiting | Phase 3 | 866 | AstraZenecaINDUSTRY | 28 | Mar 4, 2026 | clinicaltrials |
| NCT04819100 | A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC)(LIBRETTO-432) | active not recruiting | Phase 3 | 152 | Eli Lilly and CompanyINDUSTRY | 32 | Mar 4, 2026 | clinicaltrials |
| NCT04884360 | D9319C00001- 1L OC Mono Global RCT(MONO-OLA1) | active not recruiting | Phase 3 | 366 | AstraZenecaINDUSTRY | 10 | Mar 2, 2026 | clinicaltrials |
| NCT07435623 | Late Radiation Toxicities in Cervical and Endometrial Cancer: A Postoperative IMRT/Brachytherapy Study | recruiting | — | 300 | Tata Memorial HospitalOTHER_GOV | 1 | Mar 2, 2026 | clinicaltrials |
| NCT05681026 | Cultural Tailoring and Pilot Testing of an Inpatient Yoga Therapy Program for Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation in India, Tanzania, and the United States | recruiting | N/A | 60 | M.D. Anderson Cancer CenterOTHER | 3 | Feb 27, 2026 | clinicaltrials |
| NCT03256916 | Radiosensitizing Effect of Nelfinavir in Locally Advanced Carcinoma of Cervix(NELCER) | completed | Phase 3 | 348 | Tata Memorial HospitalOTHER_GOV | 1 | Feb 24, 2026 | clinicaltrials |
| NCT04172675 | A Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) | completed | Phase 2 | 107 | Janssen Research & Development, LLCINDUSTRY | 17 | Feb 24, 2026 | clinicaltrials |
| NCT07236840 | Self-administered Remote Neurological Examination Using Mobile Application in Patients With Brain Tumors(NEMO) | recruiting | — | 600 | Tata Memorial CentreOTHER | 1 | Feb 24, 2026 | clinicaltrials |
| NCT03005743 | Image Based Brachytherapy in Locally Advanced Cervical Cancers - a Randomized Controlled Trial(COMBAT-Cx) | completed | N/A | 1,050 | Tata Memorial HospitalOTHER_GOV | 1 | Feb 23, 2026 | clinicaltrials |
| NCT05022342 | Study of PIK3CA Mutations and Effectiveness and Tolerability Outcomes of Alpelisib in Real-world(SPEAR) | completed | — | 595 | Novartis PharmaceuticalsINDUSTRY | 1 | Feb 23, 2026 | clinicaltrials |
| NCT06831370 | A Study of Brentuximab Vedotin With Doxorubicin, Vinblastine and Dacarbazine in Adults With Hodgkin Lymphoma in India | recruiting | Phase 4 | 124 | TakedaINDUSTRY | 1 | Feb 23, 2026 | clinicaltrials |
| NCT05102240 | Development of Clinically High Efficient Platforms for Individualised Treatment of Cervix Cancer | recruiting | — | 1,800 | Tata Memorial HospitalOTHER_GOV | 1 | Feb 20, 2026 | clinicaltrials |
| NCT06644846 | Spatially Fractionated Radiation Treatment for Gynaecological Cancers | recruiting | N/A | 20 | Tata Memorial HospitalOTHER_GOV | 1 | Feb 20, 2026 | clinicaltrials |
| NCT05386550 | Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN, High Risk, Cisplatin-ineligible Participants (XRAY VISION) | terminated | Phase 3 | 166 | EMD Serono Research & Development Institute, Inc.INDUSTRY | 26 | Feb 19, 2026 | clinicaltrials |
| NCT03997110 | Palliative Radiation for Advanced Cervical Cancer(RAPPAL) | recruiting | N/A | 230 | Tata Memorial HospitalOTHER_GOV | 1 | Feb 17, 2026 | clinicaltrials |
| NCT07371832 | A Single Center Evaluation of AI Enabled SureForm Robotic Stapler (SureformTM) Compared to Conventional Stapler for Colorectal Cancer Procedures | recruiting | — | 200 | Asian Institute of Gastroenterology, IndiaOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT07400809 | Cervical Cancer Oligo States (Recurrence, Metastasis) Multicentre Outcomes Study.(Retro-COSMOS) | recruiting | — | 350 | Tata Memorial HospitalOTHER_GOV | 1 | Feb 17, 2026 | clinicaltrials |
| NCT06442748 | Short Versus Long-term Levetiracetam in Brain Tumors(LIBRA) | recruiting | Phase 3 | 604 | Tata Memorial CentreOTHER | 1 | Feb 13, 2026 | clinicaltrials |
| NCT07411118 | RCT of EFTR Versus STER for GIST Treatment | recruiting | N/A | 136 | Chinese University of Hong KongOTHER | 4 | Feb 13, 2026 | clinicaltrials |
| NCT07404176 | Study to Assess the Safety and Effectiveness of Novel Radiopharmaceutical Terbium-161 DOTATATE in Metastatic Neuroendocrine Tumors(TENET) | recruiting | Phase 2 | 20 | Tata Memorial HospitalOTHER_GOV | 1 | Feb 11, 2026 | clinicaltrials |
| NCT05415215 | A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer(ProHer) | completed | Phase 3 | 346 | Hoffmann-La RocheINDUSTRY | 17 | Feb 10, 2026 | clinicaltrials |
| NCT05501886 | Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1)(VIKTORIA-1) | active not recruiting | Phase 3 | 701 | Celcuity IncINDUSTRY | 23 | Feb 10, 2026 | clinicaltrials |
| NCT07196033 | Asian Gynecological Brachytherapy Registry in Cervical Cancer(AGBR-FERN-Gyn) | recruiting | — | 1,000 | Tata Memorial HospitalOTHER_GOV | 3 | Feb 9, 2026 | clinicaltrials |
| NCT07395635 | Phase II Trial of Immunonutrition in Hepatectomy | recruiting | N/A | 100 | Tata Memorial CentreOTHER | 1 | Feb 9, 2026 | clinicaltrials |
| NCT00066703 | Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer(TEXT) | completed | Phase 3 | 2,672 | ETOP IBCSG Partners FoundationNETWORK | 17 | Feb 6, 2026 | clinicaltrials |
| NCT01279135 | Tomotherapy vs Conventional Radiation for Adjuvant Pelvic RT in Ca Cervix(PARCER) | completed | Phase 3 | 300 | Tata Memorial HospitalOTHER_GOV | 1 | Feb 6, 2026 | clinicaltrials |
| NCT02763566 | A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer(MONARCH plus) | active not recruiting | Phase 3 | 463 | Eli Lilly and CompanyINDUSTRY | 4 | Feb 5, 2026 | clinicaltrials |
| NCT05478486 | Assessment of Safety, Tolerability and PK Profile of MSP008-22 in Patients With Advanced Solid Tumours | completed | Phase 1 | 7 | Godavari Biorefineries LimitedOTHER | 1 | Feb 4, 2026 | clinicaltrials |
| NCT06804135 | Systemic and Tumor Immune Response During Pelvic (Chemo)Radiation and/or Brachytherapy for Cervical Cancer(STIRR) | recruiting | — | 110 | Tata Memorial HospitalOTHER_GOV | 1 | Feb 4, 2026 | clinicaltrials |
| NCT07179757 | Clinical Outcomes and Quality of Life in Patients With Locally Advanced Vulvovaginal Cancers: Ambispective Registration Study. | recruiting | — | 200 | Tata Memorial HospitalOTHER_GOV | 1 | Feb 4, 2026 | clinicaltrials |
| NCT07290972 | Compliance to Cervical Cancer Chemoradiation Guidelines: A Multicentric Implementation Audit and Resource Assessment Initiative of National Cancer Grid of India(NCG-Compliance) | recruiting | — | 618 | Tata Memorial HospitalOTHER_GOV | 1 | Feb 4, 2026 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials